Jacob P. Thyssen

Active 1993–2025

267
Papers
25,560
Citations
91
h-index
255
i10-index

Citations

Citations per year for Jacob P. Thyssen1986: 2 citations1990: 1 citations1993: 3 citations2000: 1 citations2001: 1 citations2003: 1 citations2007: 2 citations2008: 3 citations2009: 30 citations2010: 43 citations2011: 57 citations2012: 58 citations2013: 84 citations2014: 68 citations2015: 74 citations2016: 89 citations2017: 138 citations2018: 143 citations2019: 654 citations2020: 855 citations2021: 1,113 citations2022: 973 citations2023: 1,128 citations2024: 1,605 citations2025: 885 citations2026: 9 citations1987–1989: no citations, so these years are not shown1991–1992: no citations, so these years are not shown1994–1999: no citations, so these years are not shown2002: no citations, so this year is not shown2004–2006: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,621 citing papers, 16.7% of this breakdownGermany: 790 citing papers, 8.1% of this breakdownUnited Kingdom: 663 citing papers, 6.8% of this breakdownChina: 578 citing papers, 6% of this breakdownDenmark: 554 citing papers, 5.7% of this breakdownItaly: 479 citing papers, 4.9% of this breakdownFrance: 372 citing papers, 3.8% of this breakdownNetherlands: 371 citing papers, 3.8% of this breakdownCanada: 362 citing papers, 3.7% of this breakdownSpain: 327 citing papers, 3.4% of this breakdownJapan: 304 citing papers, 3.1% of this breakdownSwitzerland: 267 citing papers, 2.8% of this breakdown
0%16.7%Other 31.2%

Fields

  • Medicine80.5%
  • Immunology and Microbiology7.1%
  • Biochemistry, Genetics and Molecular Biology4.8%
  • Pharmacology, Toxicology and Pharmaceutics1.3%
  • Environmental Science1.3%
  • Engineering0.9%
  • Other4.1%

Topics

  • Dermatology and Skin Diseases17.9%
  • Allergic Rhinitis and Sensitization8.4%
  • Psoriasis: Treatment and Pathogenesis7.1%
  • Contact Dermatitis and Allergies6.3%
  • Asthma and respiratory diseases5.5%
  • Food Allergy and Anaphylaxis Research3.2%
  • Other51.6%

Coauthors

All papers

Open in search
  1. ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of the European Academy of Dermatology and Venereology 2020 cited by 465

  2. European Society of Contact Dermatitis guideline for diagnostic patch testing – recommendations on best practice

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Contact Dermatitis 2015 cited by 1,417

  3. Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , - The Lancet 2020 cited by 491

  4. Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studies

    Authors: , , , , , , , , , , - Journal of the American Academy of Dermatology 2018 cited by 652

  5. Biomarkers in atopic dermatitis—a review on behalf of the International Eczema Council

    Authors: , , , , , , - Journal of Allergy and Clinical Immunology 2021 cited by 326

  6. Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial

    Authors: , , , , , , , , , , , , , , , - The Lancet 2022 cited by 237

  7. Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis

    Authors: , , , , , , , , , , - JAMA Dermatology 2020 cited by 388

  8. Multi-ancestry genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Joyce Y. Tung, Chao Tian, David A. Hinds, Atsushi Takahashi, Anja Bauerfeind, Birgit Kalb, Norbert Hübner, Jorge Esparza-Gordillo, Franz Rüschendorf, Herman T den Dekker, Johan C de Jongste, Anja Bauerfeind, Liesbeth Duijts, Fernando Rivadeneira, Jorge Esparza-Gordillo, André G Uitterlinden, Alexessander Couto Alves, Jacob P. Thyssen, Nicholas G Martin, Vincent W. V. Jaddoe, Herman T. den Dekker, Johan C. de Jongste, Albert Hofman, Patrick M A Sleiman, Jin Li, Hakon Hakonarson, Feng Li Xiao, Xian Bo Zuo, Xiao Dong Zheng, Liesbeth Duijts, Niels J. Elbert, Fernando Rivadeneira, Juan R Gonzalez, Manuel A. R. Ferreira, Nicholas G. Martin, Jordi Sunyer, Susanne Lau, Maria Pino-Yanes, Christian Gieger, Annette Peters, Scott Huntsman, Janina S. Ried, Cheng-Jian Xu, Jin Li, Patrick Sleiman, Bjarke Feenstra, Patrick Sleiman, Mads Melbye, Xian Bo Zuo, Feng Li Xiao, Xian Yin, Xue Jun Zhang, Xiao Zheng, Liang Sun, Veronique Bataille, Tim Spector, Daniel Glass, Craig E Pennell, Jordi Sunyer, Sheila J Barton, Keith M Godfrey, Mariona Bustamante, Ivan Curjuric, Ashish Kumar, Juan R Gonzalez, Nicole M Probst-Hensch, Susanne Lau, Birgit Kalb, Scott Huntsman, Esteban G. Burchard and 50 more - Nature Genetics 2015 cited by 661

  9. Real-world evidence of dupilumab efficacy and risk of adverse events: A systematic review and meta-analysis

    Authors: , , , , - Journal of the American Academy of Dermatology 2020 cited by 278

  10. Efficacy and safety of lebrikizumab in moderate-to-severe atopic dermatitis: 52-week results of two randomized double-blinded placebo-controlled phase III trials

    Authors: , , , , , , , , , , , , , , , - British Journal of Dermatology 2023 cited by 149

  11. Guidelines for diagnosis, prevention, and treatment of hand eczema

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christoph Skudlik, Radosław Śpiewak, Skaidra Valiukevičienė, Angelique N. Voorberg, Elke Weißhaar, Tove Agner - Contact Dermatitis 2021 cited by 264

  12. Incidence and prevalence of rosacea: a systematic review and meta-analysis

    Authors: , , , - British Journal of Dermatology 2018 cited by 402

  13. Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis

    Authors: , , , , , , , , , , , , , , , - JAMA Dermatology 2020 cited by 279

  14. Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phaseIIItrials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - British Journal of Dermatology 2020 cited by 379

  15. A systematic review and meta-analysis of the regional and age-related differences in atopic dermatitis clinical characteristics

    Authors: , , - Journal of the American Academy of Dermatology 2018 cited by 305

  16. Comorbidities of atopic dermatitis—what does the evidence say?

    Authors: , , , , - Journal of Allergy and Clinical Immunology 2023 cited by 162

  17. Efficacy and Safety of Upadacitinib in Patients With Moderate to Severe Atopic Dermatitis

    Authors: , , , , , , , , , , , , , , , , , - JAMA Dermatology 2022 cited by 204

  18. European and multi-ancestry genome-wide association meta-analysis of atopic dermatitis highlights importance of systemic immune regulation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Cheng‐Jian Xu, Cancan Qi, Sarah El‐Heis, Philip Titcombe, Elie Antoun, João Fadista, Carol A. Wang, Elisabeth Thiering, Baojun Wu, Sara Kress, Dilini M. Kothalawala, Latha Kadalayil, Jiasong Duan, Hongmei Zhang, Sabelo Hadebe, Thomas J. Hoffmann, Eric Jorgenson, Hélène Choquet, Neil Risch, Pål R. Njølstad, Ole A. Andreassen, Stefan Johansson, Catarina Almqvist, Tong Gong, Vilhelmina Ullemar, Robert Karlsson, Patrik K. E. Magnusson, Agnieszka Szwajda, Esteban G. Burchard, Jacob P. Thyssen, Torben Hansen, Line Lund Kårhus, Thomas Meinertz Dantoft, Alexander C.S.N. Jeanrenaud, Ahla Ghauri, Andreas Arnold, Georg Homuth, Susanne Lau, Markus M. Nöthen, Norbert Hübner, Medea Imboden, Alessia Visconti, Mario Falchi, Véronique Bataille, Pirro G. Hysi, Natalia Ballardini, Dorret I. Boomsma, Jouke‐Jan Hottenga, Martina Müller‐Nurasyid, Tarunveer S. Ahluwalia, Jakob Stokholm, Bo Chawes, Ann‐Marie Malby Schoos, Ana Esplugues, Mariona Bustamante, Benjamin A. Raby, Syed Hasan Arshad, Chris German, Tõnu Esko, Lili Milani, Andres Metspalu, Chikashi Terao, Katrina Abuabara, Mari Løset, Kristian Hveem, Bo Jacobsson, Maria Pino‐Yanes, David P. Strachan, Niels Grarup, Allan Linneberg and 32 more - Nature Communications 2023 cited by 135

  19. Skin biomarkers predict development of atopic dermatitis in infancy

    Authors: , , , , , , , , , , , , , , , , , - Allergy 2022 cited by 83

  20. The role of bacterial skin infections in atopic dermatitis: expert statement and review from the International Eczema Council Skin Infection Group

    Authors: , , , , , , , , , , , , , , , - British Journal of Dermatology 2019 cited by 214

  21. Contact dermatitis

    Authors: , , , , , , , , - Nature Reviews Disease Primers 2021 cited by 138

  22. Safety of upadacitinib in moderate-to-severe atopic dermatitis: An integrated analysis of phase 3 studies

    Authors: , , , , , , , , , , , , , - Journal of Allergy and Clinical Immunology 2022 cited by 63

  23. Safety of tralokinumab in adult patients with moderate-to-severe atopic dermatitis: pooled analysis of five randomized, double-blind, placebo-controlled phase II and phase III trials

    Authors: , , , , , , , , , , , , - British Journal of Dermatology 2022 cited by 74

  24. Prevalence, incidence, and severity of hand eczema in the general population – A systematic review and meta‐analysis

    Authors: , , , , - Contact Dermatitis 2021 cited by 162